EGFR and cancer: Although there is currently no literature directly addressing the interaction between c-MET/HGF/EGFR and the cGAS-STING signaling pathway, studies have found that MET-induced CD73 can inhibit the immunogenicity of STING-mediated EGFR mutant cancer (23), suggesting that the cMET/HGF/EGFR signaling pathway indirectly affects the cGAS-STING signaling pathway.